Jeff Stein, PhD, join Sofinnova Ventures as a venture partner to finance this drug from the beginning and aren't they already partnered with Bayer for commercialization of Tedizolid Phosphate (TR-701), July 2011?
Those have been up for the past couple of weeks. Looks like they might be thinking of marketing it themselves. Personally, I would rather see them acquired. It is an expensive propostion to market yourself. Expect dilution if they go down that path